Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q77827543)
Watch
English
Two first-line therapies in the treatment of mild asthma: use of peak flow variability as a predictor of effectiveness
scientific article published on 01 May 1999
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10353583
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10353583%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 December 2019
title
Two first-line therapies in the treatment of mild asthma: use of peak flow variability as a predictor of effectiveness
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10353583
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10353583%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 December 2019
main subject
asthma
1 reference
based on heuristic
inferred from title
author name string
R A Nathan
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10353583
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10353583%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 December 2019
M C Minkwitz
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10353583
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10353583%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 December 2019
C M Bonuccelli
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10353583
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10353583%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 December 2019
publication date
1 May 1999
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10353583
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10353583%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 December 2019
published in
Annals of Allergy, Asthma & Immunology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10353583
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10353583%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 December 2019
volume
82
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10353583
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10353583%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 December 2019
issue
5
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10353583
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10353583%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 December 2019
page(s)
497-503
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10353583
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10353583%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 December 2019
cites work
Peak expiratory flow variation and bronchial hyperresponsiveness in asthmatic children during periods of antigen avoidance and reexposure
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962728-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Validity of peak expiratory flow rate variability for the diagnosis of asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962728-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Peak expiratory flow variability and bronchial responsiveness to methacholine. An epidemiologic study in 117 workers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962728-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The normal range of diurnal changes in peak expiratory flow rates. Relationship to symptoms and respiratory disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962728-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Peak flow lability: association with asthma and spirometry in an older cohort
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962728-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962728-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962728-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A comparison of fluticasone propionate 200 micrograms/day with beclomethasone dipropionate 400 micrograms/day in adult asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962728-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A Comparison of the Effects of bid and qid Dosing on Compliance with Inhaled Flunisolide
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962728-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Measuring compliance with inhaled medication in asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962728-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lung function improvement in asthma with a cysteinylleukotriene receptor antagonist
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962728-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Zafirlukast for symptomatic mild-to-moderate asthma: a 13-week multicenter study. The Zafirlukast Trialists Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962728-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1081-1206(10)62728-7
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10353583
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10353583%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 December 2019
PubMed publication ID
10353583
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10353583
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10353583%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
